Medicare Enrolled

Dr. Steven Goodman, M.D.

Pathology - Anatomic · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9600 DATAPOINT DR, San Antonio, TX 78229
2108923700
In practice since 2010 (15 years)
NPI: 1538480280 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goodman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goodman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goodman

Dr. Steven Goodman is a pathology - anatomic specialist in San Antonio, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Goodman performed 758 Medicare services across 620 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goodman received a total of $369 from 4 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goodman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 758 Medicare services $369 industry payments

Medicare Practice Summary

Medicare Utilization ↗
758
Medicare services
Bottom 38% in TX for pathology - anatomic
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
620
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity 149 $28 $289
Pathology examination of tissue using a microscope, moderately low complexity 106 $9 $178
Fine needle aspiration biopsy using ultrasound guidance, first growth 98 $101 $450
Cell examination of specimen, selective cellular enhancement technique 95 $21 $198
Tissue staining for diagnosis, additional 88 $21 $157
Pathology examination of tissue using a microscope, limited examination 58 $3 $49
Preparation of tissue for examination by removing any calcium present 42 $9 $67
Pathology examination of tissue using a microscope, moderately high complexity 25 $62 $383
Tissue staining for diagnosis, initial 23 $26 $161
Fine needle aspiration biopsy using ultrasound guidance, each additional growth 21 $46 $450
Evaluation of fine needle aspirate with interpretation and report 20 $53 $275
Special stained specimen slides to identify organisms including interpretation and report 19 $20 $121
Pathology examination of tissue using a microscope 14 $5 $126
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$369
Total received (2018-2024)
Avg $123/year across 3 years
Top 21% in TX for pathology - anatomic
4
Companies
9
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$369 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$232
2023
$125
2018
$12

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Hologic Sales and Service, LLC
$218
Amgen Inc.
$125
Roche Diagnostics Corporation
$14
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 96.8% of total payments
Associated products mentioned in payments ›
APTIMA · BenchMark ULTRA · EVENITY · JADENU · THINPREP 2000 PROCESSOR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $49 per 100 Medicare services performed
Looking for a pathology - anatomic specialist in San Antonio?
Compare pathology - anatomics in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pathology - anatomics nearby

Geographic Context

Pathology - anatomics within 10 mi
140
Per 100K population
6.9
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Goodman is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Goodman experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Goodman performed 149 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goodman receive payments from pharmaceutical companies?
Yes. Dr. Goodman received a total of $369 from 4 companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goodman's costs compare to other pathology - anatomics in San Antonio?
Dr. Goodman's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goodman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →